87 related articles for article (PubMed ID: 36399116)
1. Meta-analysis of pazopanib and trabectedin effectiveness in previously treated metastatic synovial sarcoma (second-line setting and beyond).
Carroll C; Patel N; Gunsoy NB; Stirnadel-Farrant HA; Pokras S
Future Oncol; 2022 Oct; 18(32):3651-3665. PubMed ID: 36399116
[TBL] [Abstract][Full Text] [Related]
2. Protocol for the 2ND-STEP study, Japan Clinical Oncology Group study JCOG1802: a randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib.
Endo M; Kataoka T; Fujiwara T; Tsukushi S; Takahashi M; Kobayashi E; Yamada Y; Tanaka T; Nezu Y; Hiraga H; Wasa J; Nagano A; Nakano K; Nakayama R; Hamada T; Kawano M; Torigoe T; Sakamoto A; Asanuma K; Morii T; Machida R; Sekino Y; Fukuda H; Oda Y; Ozaki T; Tanaka K
BMC Cancer; 2023 Mar; 23(1):219. PubMed ID: 36890471
[TBL] [Abstract][Full Text] [Related]
3. Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma.
Stacchiotti S; Mir O; Le Cesne A; Vincenzi B; Fedenko A; Maki RG; Somaiah N; Patel S; Brahmi M; Blay JY; Boye K; Sundby Hall K; Gelderblom H; Hindi N; Martin-Broto J; Kosela H; Rutkowski P; Italiano A; Duffaud F; Kobayashi E; Casali PG; Provenzano S; Kawai A
Oncologist; 2018 Jan; 23(1):62-70. PubMed ID: 28754721
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: a systematic review.
Sharma S; Takyar S; Manson SC; Powell S; Penel N
BMC Cancer; 2013 Aug; 13():385. PubMed ID: 23937858
[TBL] [Abstract][Full Text] [Related]
5. Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study.
Bilici A; Koca S; Karaagac M; Aydin SG; Eraslan E; Kaplan MA; Ocak B; Goksu SS; Paydas S; Akgul F; Derin S; Ergun Y; Yekeduz E; Erol C; Ozyukseler DT; Demiray AG; Karaca M; Guc ZG; Menekse S; Cinkir HY; Gumusay O; Sakin A; Ozkul O; Demir H; Erdem D; Besiroglu M; Unal OU; Acar R; Koral L; Sahin S; Sakalar T; Bahceci A; Ozveren A; Gunaydin UM; Seker MM; Sunar V; Dal P; Artac M; Turhal S
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8243-8253. PubMed ID: 37067546
[TBL] [Abstract][Full Text] [Related]
6. Systemic Treatment for Adults with Synovial Sarcoma.
Desar IME; Fleuren EDG; van der Graaf WTA
Curr Treat Options Oncol; 2018 Mar; 19(2):13. PubMed ID: 29516254
[TBL] [Abstract][Full Text] [Related]
7. Treatment patterns and outcomes in patients with metastatic synovial sarcoma in France, Germany, Italy, Spain and the UK.
Patel N; Pokras S; Ferma J; Casey V; Manuguid F; Culver K; Bauer S
Future Oncol; 2023 Jun; 19(18):1261-1275. PubMed ID: 37139794
[No Abstract] [Full Text] [Related]
8. Optimal Prognostic Factors for Metastatic and Inoperable Sarcomas Treated With Pazopanib, Eribulin, and Trabectedin.
Iwai T; Hoshi M; Oebisu N; Takada N; Ban Y; Yao H; Nakamura H
In Vivo; 2023; 37(6):2634-2641. PubMed ID: 37905627
[TBL] [Abstract][Full Text] [Related]
9. Factors predictive of second-line chemotherapy in soft tissue sarcoma: An analysis of the National Genomic Profiling Database.
Mochizuki T; Ikegami M; Akiyama T
Cancer Sci; 2024 Feb; 115(2):575-588. PubMed ID: 38115234
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of second and third lines of treatment in advanced soft tissue sarcomas: a real-world study.
Gutierrez-Sainz L; Martinez-Fdez S; Pedregosa-Barbas J; Peña J; Alameda M; Viñal D; Villamayor J; Martinez-Recio S; Perez-Wert P; Pertejo-Fernandez A; Gallego A; Martinez-Marin V; Zamora P; Espinosa E; Mendiola M; Feliu J; Redondo A
Clin Transl Oncol; 2023 Dec; 25(12):3519-3526. PubMed ID: 37329429
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of sarcoma cases in which long-term disease control was achieved with trabectedin treatment: A retrospective study.
Ohmoto A; Nakano K; Fukuda N; Wang X; Urasaki T; Hayashi N; Suto H; Udagawa S; Oki R; Sato Y; Yunokawa M; Ono M; Saito M; Minami Y; Hayakawa K; Tanizawa T; Ae K; Matsumoto S; Tomomatsu J; Takahashi S
PLoS One; 2023; 18(3):e0280508. PubMed ID: 36857355
[TBL] [Abstract][Full Text] [Related]
12. Multicenter real-world experience of the clinical efficacy and tolerance of pazopanib in high-risk pediatric solid tumors (PazoPed).
Brizini M; Naccache L; Tibout P; Goudie C; Budd C; Vairy S; Brisson MC; Tran TH; Santiago R
Pediatr Hematol Oncol; 2023; 40(7):643-658. PubMed ID: 36825687
[TBL] [Abstract][Full Text] [Related]
13. Trabectedin and low-dose radiation therapy in patients with advanced leiomyosarcoma.
Martin-Broto J; Olarte-García A; Fernandéz-Rodríguez R; Ferreira MR; Carrasco-García I; Galvez-Montosa F; Rincon-Perez I; Peinado-Serrano J; Azinovic I; Guzman-Gomez L; Salgado L; Sevillano A; Ortega J; Alvarez C; Gutierrez A; Moura DS; Hindi N
Ther Adv Med Oncol; 2024; 16():17588359231225044. PubMed ID: 38288156
[TBL] [Abstract][Full Text] [Related]
14. Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations.
In GK; Hu JS; Tseng WW
Ther Adv Med Oncol; 2017 Aug; 9(8):533-550. PubMed ID: 28794805
[TBL] [Abstract][Full Text] [Related]
15. Early progression of a pancreatic metastasis of synovial sarcoma after pancreatectomy.
Okazaki M; Katano K; Sugita H; Tokoro T; Gabata R; Takada S; Nakanuma S; Makino I; Yagi S
Surg Case Rep; 2023 Feb; 9(1):30. PubMed ID: 36847976
[TBL] [Abstract][Full Text] [Related]
16. Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma.
Landuzzi L; Manara MC; Pazzaglia L; Lollini PL; Scotlandi K
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568703
[TBL] [Abstract][Full Text] [Related]
17. A Clear Cell Sarcoma Case: A Diagnostic and Treatment Challenge, with a Promising Response to Trabectedin.
Galera M; Álvarez R; Arregui M; Paniagua M; Álvarez A; González Crisostomo RA; Díazgranados A; Gutiérrez N; Calles A; Agra C
Case Rep Oncol; 2023; 16(1):1542-1550. PubMed ID: 38074516
[TBL] [Abstract][Full Text] [Related]
18. Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin.
Desar IM; Constantinidou A; Kaal SE; Jones RL; van der Graaf WT
Cancer Manag Res; 2016; 8():95-104. PubMed ID: 27574465
[TBL] [Abstract][Full Text] [Related]
19. Tumor size and surgical margins are important prognostic factors of synovial sarcoma - A retrospective study.
Sacchetti F; Alsina AC; Muratori F; Scoccianti G; Neri E; Kaya H; Sabah D; Capanna R; Campanacci DA
J Orthop; 2023 Aug; 42():74-79. PubMed ID: 37533628
[TBL] [Abstract][Full Text] [Related]
20. Trabectedin and Radiotherapy in Endometrial Stromal Sarcoma: A Case Report.
Carrasco García I; Benedetti Pedroza J; Miras Rodriguez I; Rincón I
Case Rep Oncol; 2024; 17(1):82-90. PubMed ID: 38213958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
